[{"address1": "50 Parker Court", "address2": "Unit 1", "city": "Pinkenba", "state": "QLD", "zip": "4008", "country": "Australia", "phone": "61 7 3860 3700", "fax": "61 7 3260 1225", "website": "https://www.impedimed.com", "industry": "Medical Devices", "sector": "Healthcare", "longBusinessSummary": "ImpediMed Limited, a medical technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. The company offers SOZO, a noninvasive BIS device for the assessment of lymphedema, and deliver snapshot of fluid status and tissue composition; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. It sells its devices to hospitals and clinics. The company was incorporated in 1999 and is headquartered in Pinkenba, Australia.", "fullTimeEmployees": 76, "companyOfficers": [{"maxAge": 1, "name": "Mr. Shashi  Tripathi", "title": "Chief Operating Officer", "fiscalYear": 2023, "totalPay": 422066, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. McGregor  Grant BEc, C.A., FCIS, GAICD", "title": "CFO & Executive Chairman", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Parmjot  Bains M.D.", "title": "CEO & MD", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dennis  Schlaht", "title": "Senior Vice President of R&D and Technology", "fiscalYear": 2023, "totalPay": 314251, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Lisa  Prom", "title": "Vice President of Sales", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Joann  Yao", "title": "Chief Strategy Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Steven  Chen M.B.A., M.D.", "title": "Chief Medical Center", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Leanne  Ralph AAICD, ACIS, BBus", "title": "Company Secretary", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Walton A. Taylor", "title": "Medical Director", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.065, "open": 0.065, "dayLow": 0.065, "dayHigh": 0.065, "regularMarketPreviousClose": 0.065, "regularMarketOpen": 0.065, "regularMarketDayLow": 0.065, "regularMarketDayHigh": 0.065, "beta": 2.944, "volume": 309, "regularMarketVolume": 309, "averageVolume": 8711, "averageVolume10days": 5200, "averageDailyVolume10Day": 5200, "marketCap": 139486096, "fiftyTwoWeekLow": 0.0386, "fiftyTwoWeekHigh": 0.15, "priceToSalesTrailing12Months": 13.318638, "fiftyDayAverage": 0.079026, "twoHundredDayAverage": 0.1016515, "currency": "USD", "enterpriseValue": 95883016, "profitMargins": -1.8546699, "floatShares": 1758517614, "sharesOutstanding": 2023309952, "heldPercentInsiders": 0.14194, "heldPercentInstitutions": 0.13475001, "bookValue": 0.025, "priceToBook": 2.6, "lastFiscalYearEnd": 1688083200, "nextFiscalYearEnd": 1719705600, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -19497000, "lastSplitFactor": "1027:1000", "lastSplitDate": 1416182400, "enterpriseToRevenue": 9.155, "enterpriseToEbitda": -4.19, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "IPDQF", "underlyingSymbol": "IPDQF", "shortName": "IMPEDIMED LIMITED", "longName": "ImpediMed Limited", "firstTradeDateEpochUtc": 1348579800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "a96a577f-3418-3859-914e-64ab39d705f2", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.065, "recommendationKey": "none", "totalCash": 36905000, "totalCashPerShare": 0.018, "ebitda": -22882000, "totalDebt": 1273000, "quickRatio": 6.674, "currentRatio": 7.001, "totalRevenue": 10473000, "debtToEquity": 2.497, "revenuePerShare": 0.005, "returnOnAssets": -0.27575, "returnOnEquity": -0.42359, "freeCashflow": -14645875, "operatingCashflow": -12630000, "revenueGrowth": -0.154, "grossMargins": 0.86947, "ebitdaMargins": -2.18486, "operatingMargins": -2.7000399, "financialCurrency": "AUD", "trailingPegRatio": null}]